Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:8784421rdf:typepubmed:Citationlld:pubmed
pubmed-article:8784421lifeskim:mentionsumls-concept:C0003232lld:lifeskim
pubmed-article:8784421lifeskim:mentionsumls-concept:C0038035lld:lifeskim
pubmed-article:8784421lifeskim:mentionsumls-concept:C0441655lld:lifeskim
pubmed-article:8784421lifeskim:mentionsumls-concept:C0204727lld:lifeskim
pubmed-article:8784421lifeskim:mentionsumls-concept:C0205409lld:lifeskim
pubmed-article:8784421lifeskim:mentionsumls-concept:C0015852lld:lifeskim
pubmed-article:8784421lifeskim:mentionsumls-concept:C0087066lld:lifeskim
pubmed-article:8784421lifeskim:mentionsumls-concept:C0205460lld:lifeskim
pubmed-article:8784421lifeskim:mentionsumls-concept:C0529818lld:lifeskim
pubmed-article:8784421pubmed:issue7lld:pubmed
pubmed-article:8784421pubmed:dateCreated1996-10-29lld:pubmed
pubmed-article:8784421pubmed:abstractTextSelective growth inhibition against IL-6 dependent cells was detected in fermentation extracts of a fungal strain FO-4649 which was characterized as Sporothrix species. An active metabolite (1) termed chlovalicin was isolated together with ovalicin and two other ovalicin derivatives (compounds 3 and 4). Chlovalicin, a ovalicin derivative with a chlorinated methylene moiety at the C-1 position of the cyclohexane ring, dose-dependently inhibited the growth of IL-6 dependent MH60 cells (IC50, 7.5 microM) in the presence of 0.2 U/ml IL-6 and, to a lesser extent, the growth of B16 melanoma cells (IC50, 38 microM). Among the other three compounds, only ovalicin showed inhibitory activity (IC50, 27 microM) against MH60 cells. These four compounds did not show any antimicrobial activity at a concentration of 1000 micrograms/ml.lld:pubmed
pubmed-article:8784421pubmed:languageenglld:pubmed
pubmed-article:8784421pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:citationSubsetIMlld:pubmed
pubmed-article:8784421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:8784421pubmed:statusMEDLINElld:pubmed
pubmed-article:8784421pubmed:monthJullld:pubmed
pubmed-article:8784421pubmed:issn0021-8820lld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:HayashiMMlld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:TanakaHHlld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:OmuraSSlld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:KimY PYPlld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:KomiyamaKKlld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:TakamatsuSSlld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:KomiyaTTlld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:MasumaRRlld:pubmed
pubmed-article:8784421pubmed:authorpubmed-author:PreeprameSSlld:pubmed
pubmed-article:8784421pubmed:issnTypePrintlld:pubmed
pubmed-article:8784421pubmed:volume49lld:pubmed
pubmed-article:8784421pubmed:ownerNLMlld:pubmed
pubmed-article:8784421pubmed:authorsCompleteYlld:pubmed
pubmed-article:8784421pubmed:pagination631-4lld:pubmed
pubmed-article:8784421pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:meshHeadingpubmed-meshheading:8784421-...lld:pubmed
pubmed-article:8784421pubmed:year1996lld:pubmed
pubmed-article:8784421pubmed:articleTitleChlovalicin, a new cytocidal antibiotic produced by Sporothrix sp. FO-4649. I. Taxonomy, fermentation, isolation and biological activities.lld:pubmed
pubmed-article:8784421pubmed:affiliationKitasato Institute, Kitasato University, Tokyo, Japan.lld:pubmed
pubmed-article:8784421pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:8784421pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed